All In Biotech

Free tool

FAERS Monitor: Gvoke Kit

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 212097 or its brand name (Gvoke Kit, Glucagon). Reports on generic versions are filed under their own applications.

Reports

16

Serious

7

44% of reports

Hospitalization

3

Death reported

3

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood glucose decreased3
  • constipation2
  • death2
  • dizziness2
  • screaming2
  • abdominal pain1
  • abdominal pain upper1
  • aphasia1
  • arthralgia1
  • atrial fibrillation1
  • blood creatinine increased1
  • blood pressure systolic decreased1
  • blood urea increased1
  • bradycardia1
  • breast cancer metastatic1

Reports by year received

View as table
YearReports
20061
20141
20203
20211
20221
20232
20241
20253
20263

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,143 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
screaming2412.9112.9462
blood pressure systolic decreased1289.043.371
breast cancer metastatic1122.518.430
blood glucose decreasedSignal382.129.6167
blood urea increased178.511.819
aphasia143.56.510
bradycardia124.83.75
blood creatinine increased120.13.04
atrial fibrillation113.52.02
constipation212.13.311
abdominal pain upper16.41.01
abdominal pain15.70.81
dizziness25.31.43
arthralgia13.20.50
death23.10.81

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.